Clozaril
| Generic Name: | clozapine |
| Company: | Novartis |
| Web Site: | www.clozaril.com/index.jsp |
| Country: | USA |
| |
 |
Description: |
Clozaril (clozapine), an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine. |
| |
| Indications: | Clozaril (clozapine) is indicated for the management of severely ill schizophrenic patients who fail to respond adequately to standard drug treatment for schizophrenia.
Because of the significant risk of agranulocytosis and seizure associated with its use, Clozaril should be used only in patients who have failed to respond adequately to treatment with appropriate courses of standard drug treatments for schizophrenia, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs.
Revised April 2009 |
| |
| |
| |
|
|
|
|
Additional Information
Medications for
Mental Illness
Your Child
and Medications
Bipolar
Disorder
Schizophrenia
Guide
Depression
|
